Patents Assigned to Merck Patents GmbH
  • Patent number: 9051233
    Abstract: The present invention relates to compounds of the formula (1), to the use thereof in electronic devices, and to electronic devices, particularly organic electroluminescence devices, comprising said compounds according to the invention, particularly as blue emitting material in an emitting layer.
    Type: Grant
    Filed: May 20, 2009
    Date of Patent: June 9, 2015
    Assignee: Merck Patent GmbH
    Inventors: Arne Buesing, Holger Heil, Philipp Stoessel
  • Patent number: 9051307
    Abstract: The present invention relates to novel bipyridyl derivatives of formula (I) and to the use of such compounds in which the inhibition, regulation and/or modulation of signal transduction by ATP consuming proteins like kinases plays a role, particularly to inhibitors of TGF-beta receptor kinases, and to the use of such compounds for the treatment of kinase-induced diseases, in particular for the treatment of tumors.
    Type: Grant
    Filed: July 29, 2014
    Date of Patent: June 9, 2015
    Assignee: Merck Patent GmbH
    Inventors: Guenter Hoelzemann, Dieter Dorsch, Alfred Jonczyk, Christiane Amendt, Frank Zenke
  • Publication number: 20150152059
    Abstract: The invention relates to solid state forms of N—((S)-2,3-Dihydroxy-propyl)-3-(2-fluoro-4-iodo-phenylamino)-isonicotinamide, processes for their preparation, and medical uses thereof.
    Type: Application
    Filed: May 7, 2013
    Publication date: June 4, 2015
    Applicant: Merck Patent GmbH
    Inventors: Axel Becker, Christoph Saal, Clemens Kuehn, Donald Bankston, Marco Poma
  • Publication number: 20150152104
    Abstract: Compounds of the formula (I) in which R, R1, R2 and R3 have the meanings indicated in Claim 1, are inhibitors of PDK1 and cell proliferation/cell vitality and can be employed for the treatment of tumours.
    Type: Application
    Filed: February 6, 2015
    Publication date: June 4, 2015
    Applicant: MERCK PATENT GMBH
    Inventors: Dieter DORSCH, Christian SIRRENBERG, Thomas J.J. MUELLER, Eugen MERKUL, Gnuni Amatunu KARAPETYAN
  • Publication number: 20150155494
    Abstract: The invention generally relates to organic semiconductor formulations for use in organic semiconductor layers of organic electronic devices, and more specifically in organic field effect transistors, to organic semiconductor layers prepared from such formulations, and to organic electronic devices and organic field effect transistors encompassing such organic semiconductor layers.
    Type: Application
    Filed: June 14, 2013
    Publication date: June 4, 2015
    Applicant: MERCK PATENT GMBH
    Inventors: Li Wei Tan, Rashmi Bhintade, Piotr Wierzchowiec, Changsheng Wang, Nicolas Blouin
  • Publication number: 20150153257
    Abstract: A sample preparation device, preferably for sterility testing, comprising a manifold including one or more receptacles for filtration units and at least one inlet and/or outlet port. The receptacle(s) is/are respectively provided with one or more connectors for establishing a fluid connection with mating ports of the filtration units and media containers/vials upon insertion of the same into the respective receptacles. The connectors are in fluid communication with the inlet and outlet port(s) via channels defined in the manifold to allow a desired fluid transfer through the manifold.
    Type: Application
    Filed: June 14, 2013
    Publication date: June 4, 2015
    Applicant: MERCK PATENT GMBH
    Inventors: Stephane Olivier, Pierre Guedon, Florian Allard
  • Publication number: 20150152328
    Abstract: The improved method for the etching of transparent conductive oxide layers placed on flexible polymer substrates, hard substrates like glass or on silicon wafers comprises the use of new etching pastes, which are activated by irradiation.
    Type: Application
    Filed: May 7, 2013
    Publication date: June 4, 2015
    Applicant: Merck patent GmbH
    Inventors: Jun Nakanowatari, Tomohisa Goto
  • Patent number: 9045687
    Abstract: The invention relates to carbodiimide compounds of the general formula (I) EA2-ySi(CN2)4-xOx:Euy where EA stands for one or more elements selected from Mg, Ca, Sr, Ba or Zn and x stands for a value from the range from 0 to 3.9 and Y stands for a value from the range from 0.01 to 0.4, and a process for the preparation of these phosphors and the use thereof as conversion phosphors or in lamps.
    Type: Grant
    Filed: June 24, 2011
    Date of Patent: June 2, 2015
    Assignee: MERCK PATENT GMBH
    Inventors: Holger Winkler, Andreas Benker, Ralf Petry, Tim Vosgroene
  • Patent number: 9045682
    Abstract: The invention relates to a liquid-crystalline medium based on a mixture of polar compounds having negative dielectric anisotropy, which contains at least one compound of the formula I and at least one compound of the formula II in which R1, R2, R3, R4, ring A, Z1, Z2 and m are as defined in Claim 1, and to the use thereof for an active-matrix display based on the ECB, VA, PS-VA, FFS, PALC or IPS effect.
    Type: Grant
    Filed: May 1, 2013
    Date of Patent: June 2, 2015
    Assignee: Merck Patent GmbH
    Inventors: Norihiko Tanaka, Makoto Murakami, Shinji Nakajima
  • Patent number: 9044409
    Abstract: The invention relates to the use of chromen-4-one derivatives of the formula I where R1 and R2 may be identical or different and are selected from H, —C(?O)—R7, —C(?O)—OR7, alkyl groups, alkenyl groups, hydroxyalkyl groups and/or cycloalkyl groups and/or cycloalkenyl groups, R3 is H or alkyl groups, R4 is H or OR8, R5 and R6 are selected from —H, —OH, alkyl groups, alkenyl groups and hydroxyalkyl groups, and R7 is H, alkyl groups, a polyhydroxyl compound, such as, preferably, an ascorbic acid radical or glycosidic radicals, and R8 is H or alkyl groups, where at least two of the substituents R1, R2 and R4-R6 are different from H or at least one substituent from R1 and R2 is —C(?O)—R7 or —C(?O)—OR7, for the care, preservation or improvement of the general state of the skin or hair.
    Type: Grant
    Filed: October 9, 2007
    Date of Patent: June 2, 2015
    Assignee: Merck Patent GmbH
    Inventors: Christophe Carola, Herwig Buchholz, Sylvia Huber, Ralf Rosskopf
  • Patent number: 9045493
    Abstract: Compounds of the formula I are inhibitors of TBK1 and IKK? and can be employed, inter alia, for the treatment of cancer and inflammatory diseases.
    Type: Grant
    Filed: January 3, 2013
    Date of Patent: June 2, 2015
    Assignee: MERCK PATENT GMBH
    Inventors: Hans Michael Eggenweiler, Guenter Hoelzemann, Dieter Dorsch
  • Patent number: 9048433
    Abstract: The invention relates to novel polymers containing one or more thieno[3,2-b]thiophene-2,5-dione and/or furo[3,2-b]furan-2,5-dionerepeating units or their thioketone derivatives, monomers and methods for their preparation, their use as semiconductors in organic electronic (OE) devices, especially in organic photovoltaic (OPV) devices, and to OE and OPV devices comprising these polymers.
    Type: Grant
    Filed: November 17, 2011
    Date of Patent: June 2, 2015
    Assignee: MERCK PATENT GMBH
    Inventors: Nicolas Blouin, Steven Tierney, William Mitchell, Miguel Carrasco-Orozco
  • Patent number: 9045683
    Abstract: The present invention relates to polymerizable compounds, to processes and intermediates for the preparation thereof, and to the use thereof for optical, electro-optical and electronic purposes, in particular in liquid-crystal (LC) media and LC displays, especially in LC displays of the PS (“polymer sustained”) or PSA (“polymer sustained alignment”) type.
    Type: Grant
    Filed: June 1, 2011
    Date of Patent: June 2, 2015
    Assignee: Merck Patent GmbH
    Inventors: Andreas Taugerbeck, Achim Goetz, Stephan Derow
  • Publication number: 20150146155
    Abstract: The present invention relates to a liquid crystal (LC) medium, to its use for optical, electro-optical and electronic purposes, in particular in LC displays, especially in LC displays of the PS (“polymer sustained”) or PSA (“polymer sustained alignment”) type, and to LC displays, especially PS or PSA displays, comprising said LC medium.
    Type: Application
    Filed: May 21, 2013
    Publication date: May 28, 2015
    Applicant: Merck Patent GmbH
    Inventors: Martin Engel, Melanie Klasen-Memmer, Christoph Marten, Stephan Derow
  • Publication number: 20150144847
    Abstract: The invention relates to novel conjugated polymers containing one or more repeating units derived from indacenodibenzothiophene or dithia-dicyclopenta-dibenzothiophene, to methods for their preparation and educts or intermediates used therein, to polymer blends, mixtures and formulations containing them, to the use of the polymers, polymer blends, mixtures and formulations as organic semiconductors in organic electronic (OE) devices, especially in organic photovoltaic (OPV) devices and organic photodetectors (OPD), and to OE, OPV and OPD devices comprising these polymers, polymer blends, mixtures or formulations.
    Type: Application
    Filed: April 2, 2013
    Publication date: May 28, 2015
    Applicant: MERCK PATENT GMBH
    Inventors: Mansoor D'Lavari, William Mitchell, Changsheng Wang, Steven Tierney, David Sparrowe
  • Publication number: 20150148351
    Abstract: The present invention relates to 3-(1-{3-[5-(1-methyl-piperidin-4-ylmethoxy)-pyrimidin-2-yl]-benzyl}-6-oxo-1,6-dihydro-pyridazin-3-yl)-benzonitrile hydrochloride solvates and crystalline modifications thereof. The present invention further relates to processes of manufacturing these crystalline modifications as well as their use in the treatment and/or prophylaxis of physiological and/or pathophysiological conditions, which are caused, mediated and/or propagated by the inhibition, regulation and/or modulation of signal transduction of kinases, in particular by the inhibition of tyrosine kinases, e.g. pathophysiological conditions such as cancer.
    Type: Application
    Filed: January 29, 2015
    Publication date: May 28, 2015
    Applicant: MERCK PATENT GMBH
    Inventors: Axel BECKER, Clemens KUEHN, Christoph SAAL, Oliver SCHADT, Dieter DORSCH, Heinz-Hermann BOKEL, Frank STIEBER, Cristina DONINI
  • Publication number: 20150144846
    Abstract: The invention relates to novel compounds containing one or more units derived from 1,5-disubstituted-1,5-dihydro-[1,5]naphthyridine-2,6-dione, to methods for their preparation and educts or intermediates used therein, to mixtures and formulations containing them, to the use of the compounds, mixtures and formulations as organic semiconductors in organic electronic (OE) devices, especially in organic photovoltaic (OPV) devices and organic photodetectors (OPD), and to OE, OPV and OPD devices comprising these compounds, mixtures or formulations.
    Type: Application
    Filed: May 6, 2013
    Publication date: May 28, 2015
    Applicant: MERCK PATENT GmbH
    Inventors: Lana Nanson, Nicolas Blouin, William Mitchell, Steven Tierney, Toby Cull
  • Patent number: 9040172
    Abstract: The present invention describes novel indenofluorene derivatives which can preferably be employed as matrix materials for phosphorescent dopants or as electron-transport materials, in particular for use in the emission and/or charge-transport layer of electroluminescent devices. The invention furthermore relates to polymers which comprise these compounds as structural units and to a process for the preparation of the compounds according to the invention and to electronic devices which comprise same.
    Type: Grant
    Filed: June 1, 2010
    Date of Patent: May 26, 2015
    Assignee: Merck Patent GmbH
    Inventors: Amir Hossain Parham, Christof Pflumm, Teresa Mujica-Fernaud, Arne Buesing, Holger Heil
  • Patent number: 9040560
    Abstract: The invention provides novel substituted amino azaheterocyclic carboxamide compounds according to Formula (I), their manufacture and use for the treatment of hyperproliferative diseases, such as cancer.
    Type: Grant
    Filed: December 13, 2013
    Date of Patent: May 26, 2015
    Assignee: Merck Patent GmbH
    Inventors: Amanda E. Sutton, Thomas E. Richardson, Bayard R. Huck, Srinivasa R. Karra, Xiaoling Chen, Yufang Xiao, Andreas Goutopoulos, Ruoxi Lan, David Perrey, Harold George Vandeveer, Lesley Liu-Bujalski, Frank Stieber, Brian L. Hodous, Hui Qiu, Reinaldo C. Jones, Brian H. Heasley
  • Patent number: 9040512
    Abstract: The present invention relates, inter alia, to metal complexes having improved solubility, to processes for the preparaion of the metal complexes, to devices comprising these metal complexes and to the use of the metal complexes.
    Type: Grant
    Filed: September 1, 2011
    Date of Patent: May 26, 2015
    Assignee: Merck Patent GmbH
    Inventors: Rémi Manouk Anémian, Burkhard Koenig, Claire de Nonancourt